Supported by expanding biotechnology investment and regenerative medicine research, the automated cell culture market was valued at USD 20.99 billion in the base year 2025 and is projected to reach USD 23.69 billion in 2026 and USD 63.15 billion by 2034, registering a CAGR of 13.02% during the forecast period 2026–2034. Competitive participants include Becton, Dickinson and Company, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Hamilton Company, Tecan Trading AG, Miltenyi Biotec B.V. & Co. KG, and F. Hoffmann-La Roche Ltd.

Regional Analysis of the Automated Cell Culture Market

North America dominated with nearly 48.30% share in 2025, supported by a strong presence of biopharmaceutical companies and advanced research infrastructure. In December 2025, Emory University introduced the CellXpress.ai robotic, AI-imaging cell cultivation system in the US for high-throughput organoid research, and AI-driven monitoring and continuous cell analysis are strengthening efficiency and scalability.

Europe was the second leading market, propelled by regulatory structures that facilitate bioprocessing. In December 2025, the European Commission introduced the Biotech Act, aligned with the 2024–2029 life sciences strategy, to encourage automated systems in research and production. Asia-Pacific is projected to post the highest CAGR on rising biotechnology investment in China, India, and South Korea; India's Bio-RIDE project allocated USD 1.1 billion from 2021 to 2026 for biomanufacturing and biofoundry capabilities. Latin America and the Middle East show moderate growth.

North America shows high deployment of automation for drug discovery and cellular research. In Europe, the region is focusing on developing its biotech sector through legislation and policies, with the Biotech Act placing special emphasis on healthcare. In Asia-Pacific, government measures toward research and biomanufacturing capacity building are driving innovation, and expansion of research laboratories keeps boosting the need for automated cell culturing devices. In the rest of the world, laboratories and healthcare institutes are introducing automation to improve the efficiency of cell culturing procedures.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/automated-cell-culture-market

Regenerative Medicine and Stem Cell Research

Stem cell research is expected to witness the highest application growth during the forecast period as demand rises for regenerative medicines and novel treatments, and automation provides better control of cell growth parameters. Because reproducibility and reliability are crucial in research and bioprocess development, cell-handling automation is gaining importance across laboratories.

Product launches illustrate this momentum. In May 2024, Sinfonia Technology supplied its CellQualia Intelligent Cell Processing System in Japan to automate cell cultures for quality regenerative medicine manufacturing, and in January 2024 Thermo Fisher Scientific launched the CTS Cellmation software platform in the United States to integrate tools for cell therapy automation.

Future Trends: Autonomous Labs and Digital Twins

Strategic trends point toward AI predictive systems that optimize cell growth without manual operations. Autonomous labs are projected to gain popularity as organizations seek to minimize human interference in lab operations, while digital twin technology simulates the laboratory environment for real-time analysis. Scalable automation platforms and AI labs are expected to define the next phase of the market.

AI-based integration into automation offers promising growth potential, and the report points to AI labs as a defining trend for the next phase of laboratory automation.

Regulation and Competitive Structure

Regulation centers on process standardization, contamination management, and data integrity. Authorities such as the U.S. Food and Drug Administration and the European Medicines Agency set guidelines for automated bioprocessing systems, and companies must follow GMP guidelines to keep processes traceable, reproducible, and validated.

The competitive structure is concentrated, with life sciences and laboratory automation firms competing on system integration, operating speed, usability, and adherence to laboratory standards. Biopharmaceutical manufacturing and research institutions continue to shape vendor positioning.

Other companies in the market include Thermo Fisher Scientific, Sartorius AG, Danaher Corporation, Merck KGaA, Lonza Group Ltd., Corning Incorporated, PromoCell GmbH, Biospherix Ltd., Cell Culture Company, LLC, and Hitachi High-Tech Corporation.

With North America the largest market in 2025, the automated cell culture market is expected to expand from USD 23.69 billion in 2026 to USD 63.15 billion by 2034.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market